Co-Innovation Biotech Co., Ltd.

Co-Innovation Biotech Co., Ltd. — FDA 510(k) Submissions

Co-Innovation Biotech Co., Ltd. has submitted 10 FDA 510(k) premarket notifications since 2013, of which 10 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Enzyme Immunoassay, Opiates, Enzyme Immunoassay, Amphetamine, Kit, Test, Pregnancy, Hcg, Over The Counter, Enzyme Immunoassay, Barbiturate, Enzyme Immunoassay, Cannabinoids . Use the specialty filter in the sidebar to narrow results.